 |
... welcome |
|
|
As a result, this pooling of talents allows us to tackle efficiently the three major topics of the modern cancer research :
- the identification of novel targets,
- the study of the molecular mechanisms,
- the therapeutic innovations.
Our research projects are mainly devoted to solid tumors, in particular, breast, prostate and GI cancers corresponding to the clinical recruitment at the CRLC Val d’Aurelle – Paul Lamarque.
The IRCM is a milestone of « Montpellier Cancer » initiative, a research network including all the people working on cancer in Montpellier and Languedoc-Roussillon.
Thanks to its “from the bench to the bedside … and back” approach, the IRCM contributes to the National Cancer Plan and Cancéropole Grand-Sud-Ouest (Cancer clusters).
The IRCM is a joint venture between Inserm (National Health and Medical Research Organisation), le CRLC Val d’Aurelle-Paul Lamarque (Clinical Cancer Center in Montpellier) and l’Université Montpellier 1. |
|
|
|
|
|
